U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
190051190051Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNo Results AvailableSarcomaBiological: pegfilgrastim|Drug: doxorubicin hydrochloride|Drug: ifosfamide|Procedure: multimodality therapyhttps://ClinicalTrials.gov/show/NCT00061984
190052190052Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNo Results AvailableAdenocarcinoma of the Esophagus|Stage III Esophageal Cancer|Stage IV Esophageal CancerDrug: arsenic trioxidehttps://ClinicalTrials.gov/show/NCT00061958
190053190053Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedHas ResultsAcute Undifferentiated Leukemia|B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|L1 Adult Acute Lymphoblastic Leukemia|L1 Childhood Acute Lymphoblastic Leukemia|L2 Adult Acute Lymphoblastic Leukemia|L2 Childhood AcutDrug: allopurinol|Drug: cyclophosphamide|Drug: daunorubicin hydrochloride|Drug: vincristine sulfate|Drug: dexamethasone|Drug: asparaginase|Biological: filgrastim|Drug: imatinib mesylate|Drug: methotrexate|Drug: cytarabine|Drug: trimethoprim-sulfamethoxazole|Drug: mercaptopurine|Drug: leucovorin calcium|Biological: alemtuzumab|Drug: acyclovir|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00061945
190054190054Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachCompletedHas ResultsAdenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Gastric Cancer|Stage IIIB Gastric Cancer|Stage IIIC Gastric Cancer|Stage IV GastriDrug: bortezomib|Drug: irinotecanhttps://ClinicalTrials.gov/show/NCT00061932
190055190055Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: Carboplatin, etoposide & thalidomide|Drug: Carboplatin, etoposide & placebohttps://ClinicalTrials.gov/show/NCT00061919
190056190056Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNo Results AvailableHead and Neck CancerDrug: celecoxibhttps://ClinicalTrials.gov/show/NCT00061906
190057190057Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of TumorsCompletedHas ResultsSarcomaDrug: celecoxib|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: ifosfamide|Drug: vinblastine sulfate|Drug: vincristine sulfate|Procedure: conventional surgery|Radiation: radiation therapy|Drug: MESNA|Drug: Filgrastimhttps://ClinicalTrials.gov/show/NCT00061893
190058190058BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell LymphomaCompletedNo Results AvailableLymphomaDrug: forodesine hydrochloridehttps://ClinicalTrials.gov/show/NCT00061880
190059190059Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerCompletedNo Results AvailableProstate CancerDrug: pegylated liposomal doxorubicin hydrochloride|Procedure: hyperthermia treatmenthttps://ClinicalTrials.gov/show/NCT00061867
190060190060Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: soblidotinhttps://ClinicalTrials.gov/show/NCT00061854
190061190061Medical College of Georgia FitKid ProjectCompletedNo Results AvailableHealthyBehavioral: exercisehttps://ClinicalTrials.gov/show/NCT00061841
190062190062Biliary Atresia Research ConsortiumRecruitingNo Results AvailableBiliary Atresia|Cholestasishttps://ClinicalTrials.gov/show/NCT00061828
190063190063Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerCompletedNo Results AvailableColorectal CancerBiological: cetuximab|Drug: oxaliplatin|Drug: leucovorin|Drug: 5-fluorouracil|Drug: 5-fluorouracil|Biological: cetuximabhttps://ClinicalTrials.gov/show/NCT00061815
190064190064Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: risperidone, quetiapinehttps://ClinicalTrials.gov/show/NCT00061802
190065190065Imaging of Brain Receptors in Healthy Volunteers and in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: SPECT Imaging of Nicotinic Acetylcholine Receptors in Brainhttps://ClinicalTrials.gov/show/NCT00061789
190066190066NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNo Results AvailableHerpes Zoster|Neuralgia|Pain|Peripheral Nervous System Diseases|ShinglesDrug: Capsaicin Dermal Patchhttps://ClinicalTrials.gov/show/NCT00061776
190067190067Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNo Results AvailableBeta-thalassemia|Myelodysplastic Syndromes|Fanconi Syndrome|Anemia, Diamond-Blackfan|Anemia, AplasticDrug: Deferasiroxhttps://ClinicalTrials.gov/show/NCT00061763
190068190068Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNo Results AvailableBeta-ThalassemiaDrug: ICL670|Drug: deferoxaminehttps://ClinicalTrials.gov/show/NCT00061750
190069190069Quality of Life in Pediatric Inflammatory Bowel DiseaseCompletedNo Results AvailableCrohn's Disease|Ulcerative Colitishttps://ClinicalTrials.gov/show/NCT00061737
190070190070Medical and Surgical Treatment of Esophageal RefluxCompletedNo Results AvailableGastroesophageal Refluxhttps://ClinicalTrials.gov/show/NCT00061724
190071190071Alternative Therapies for Menopause: A Randomized TrialCompletedNo Results AvailableMenopause|Hot FlashesDrug: Hormone Replacement Therapy|Drug: Cimicifuga racemosa (Black Cohosh)|Drug: Multibotanical phytoestrogen formulahttps://ClinicalTrials.gov/show/NCT00061711
190072190072Treatment for Depressed Preadolescent GirlsCompletedNo Results AvailableDepressionBehavioral: Cognitive Behavior Therapy Child Only|Behavioral: CBT plus Parent Traininghttps://ClinicalTrials.gov/show/NCT00061698
190073190073Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory LymphomaCompletedNo Results AvailableLymphoma, Non-Hodgkin|Hodgkin's LymphomaDrug: ABT-510 - Thrombospondin-1 Mimetichttps://ClinicalTrials.gov/show/NCT00061672
190074190074Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNo Results AvailableSarcoma, Soft TissueDrug: ABT-510 - Thrombospondin-1 mimetichttps://ClinicalTrials.gov/show/NCT00061659
190075190075Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)TerminatedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: ABT-510/Thrombospondin-1 mimetic|Drug: Carboplatin/Taxolhttps://ClinicalTrials.gov/show/NCT00061646
190076190076Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedHas ResultsInfections, Gram-Positive Bacterial|Abscess|Burns|Cellulitis|Ulcer|Wound InfectionsDrug: Telavancin|Drug: Vancomycin or antistaphylococcal penicillinhttps://ClinicalTrials.gov/show/NCT00061633
190077190077Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesCompletedNo Results AvailableHematologic MalignanciesDrug: Tezacitabine (FMdC)https://ClinicalTrials.gov/show/NCT00061620
190078190078Measuring Levels of SMN in Blood Samples of SMA PatientsCompletedNo Results AvailableSpinal Muscular Atrophyhttps://ClinicalTrials.gov/show/NCT00061607
190079190079A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular DegenerationCompletedNo Results AvailableMacular DegenerationDrug: rhuFab V2 (ranibizumab)https://ClinicalTrials.gov/show/NCT00061594
190080190080Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital AnemiasRecruitingNo Results AvailableCongenital Hemolytic Anemia|Diamond-Blackfan AnemiaProcedure: Radiotherapy|Drug: Alemtuzumab (Campath )|Drug: Sirolimus (Rapamune )https://ClinicalTrials.gov/show/NCT00061568

* Görseller ve İçerik tekif hakkına sahip olabilir